$1.83
0.042.23%
In chiusura: Nov 17, 4:00 PM EST
$1.83
0.042.23%
Pre-mercato: 4:00 AM EST

Foghorn Therapeutics (FHTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $0.80 | $-0.25 | 420.0 % |
| Q2 | Aug 6, 2026 | $-0.10 | $-0.23 | 56.5 % |
| Q1 | May 7, 2026 | $-0.29 | $-0.31 | 6.45 % |
| Q4 | Mar 11, 2026 | $-0.34 | $-0.27 | -25.9 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $83.54M | $7.24M | 1054.5 % |
| Q2 | Aug 6, 2026 | $16.07M | $7.97M | 101.6 % |
| Q1 | May 7, 2026 | $3.27M | $8.20M | -60.2 % |
| Q4 | Mar 11, 2026 | $9.25M | $8.95M | 3.32 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.25 | $-0.23 | $-0.31 | $-0.27 |
| Actual | $0.80 | $-0.10 | $-0.29 | $-0.34 |
| Surprise | +420.0% | +56.5% | +6.45% | -25.9% |
| Revenue | ||||
| Estimate | $7.2M | $8.0M | $8.2M | $8.9M |
| Actual | $83.5M | $16.1M | $3.3M | $9.2M |
| Surprise | +1054.5% | +101.6% | -60.2% | +3.32% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.24 | $-0.25 | $-0.32 | $-0.32 |
| Revenue | ||||
| Consensus | $4.2M | $10.5M | — | — |